Viking Therapeutics, Inc. (0VQA.L)

USD 39.07

(-17.95%)

Eps Summary of Viking Therapeutics, Inc.

  • Viking Therapeutics, Inc.'s latest annual eps in 2023 was -0.91 USD , down -3.41% from previous year.
  • Viking Therapeutics, Inc.'s latest quarterly eps in 2024 Q3 was -0.22 USD , down -10.0% from previous quarter.
  • Viking Therapeutics, Inc. reported an annual eps of -0.88 USD in 2022, down -25.71% from previous year.
  • Viking Therapeutics, Inc. reported an annual eps of -0.70 USD in 2021, down -40.0% from previous year.
  • Viking Therapeutics, Inc. reported a quarterly eps of -0.20 USD for 2024 Q2, up 23.08% from previous quarter.
  • Viking Therapeutics, Inc. reported a quarterly eps of -0.22 USD for 2024 Q3, down -10.0% from previous quarter.

Annual Eps Chart of Viking Therapeutics, Inc. (2023 - 2012)

Historical Annual Eps of Viking Therapeutics, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -0.91 USD -3.41%
2022 -0.88 USD -25.71%
2021 -0.70 USD -40.0%
2020 -0.50 USD -38.89%
2019 -0.36 USD 5.26%
2018 -0.38 USD 51.9%
2017 -0.79 USD 12.22%
2016 -0.90 USD 75.54%
2015 -3.68 USD 27.56%
2014 -5.08 USD -14885.25%
2013 -0.03 USD 88.7%
2012 -0.30 USD 0.0%

Peer Eps Comparison of Viking Therapeutics, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 54.95%
Dynavax Technologies Corporation -0.05 USD -1734.677%
Supernus Pharmaceuticals, Inc. 0.02 USD 3875.934%
Perrigo Company plc -0.09 USD -869.116%
Illumina, Inc. -7.35 USD 87.619%
Thermo Fisher Scientific Inc. 15.53 USD 105.86%
Iovance Biotherapeutics, Inc. -1.89 USD 51.852%
Walgreens Boots Alliance, Inc. -10.01 USD 90.909%
IQVIA Holdings Inc. 7.39 USD 112.314%
Heron Therapeutics, Inc. -0.80 USD -13.75%
Regeneron Pharmaceuticals, Inc. 37.05 USD 102.456%
Unity Biotechnology, Inc. -2.70 USD 66.296%
Waters Corporation 10.87 USD 108.372%
Biogen Inc. 8.02 USD 111.347%
Sangamo Therapeutics, Inc. -1.48 USD 38.514%
Evolus, Inc. -1.08 USD 15.741%
Adicet Bio, Inc. -3.31 USD 72.508%
Cara Therapeutics, Inc. -2.19 USD 58.447%
bluebird bio, Inc. -1.93 USD 52.85%
Esperion Therapeutics, Inc. -2.03 USD 55.172%
FibroGen, Inc. -2.92 USD 68.836%
Agilent Technologies, Inc. 4.22 USD 121.564%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 91.174%
Homology Medicines, Inc. -7.41 USD 87.719%
Geron Corporation -0.32 USD -184.375%
Alnylam Pharmaceuticals, Inc. -3.52 USD 74.148%
Amicus Therapeutics, Inc. -0.51 USD -78.431%
Myriad Genetics, Inc. -1.39 USD 34.532%
Intellia Therapeutics, Inc. -5.42 USD 83.21%
Zoetis Inc. 5.08 USD 117.913%
Abeona Therapeutics Inc. -2.53 USD 64.032%
Mettler-Toledo International Inc. 36.10 USD 102.521%
BioMarin Pharmaceutical Inc. 0.89 USD 202.247%
Vertex Pharmaceuticals Incorporated 14.05 USD 106.477%
Kala Pharmaceuticals, Inc. -17.35 USD 94.755%
Ionis Pharmaceuticals, Inc. -2.56 USD 64.453%
Atara Biotherapeutics, Inc. -65.18 USD 98.604%
Verastem, Inc. -3.96 USD 77.02%
Nektar Therapeutics -1.45 USD 37.241%
Axsome Therapeutics, Inc. -5.27 USD 82.732%
Aclaris Therapeutics, Inc. -1.27 USD 28.346%
Sarepta Therapeutics, Inc. -5.80 USD 84.31%
OPKO Health, Inc. -0.25 USD -264.0%
Exelixis, Inc. 0.65 USD 240.0%
Neurocrine Biosciences, Inc. 2.56 USD 135.547%
Corcept Therapeutics Incorporated 1.02 USD 189.216%
Anavex Life Sciences Corp. -0.60 USD -51.667%
uniQure N.V. -6.47 USD 85.935%
Imunon, Inc. -2.16 USD 57.87%
Blueprint Medicines Corporation -8.37 USD 89.128%
Insmed Incorporated -5.34 USD 82.959%
Halozyme Therapeutics, Inc. 2.13 USD 142.723%
Agios Pharmaceuticals, Inc. -6.33 USD 85.624%
TG Therapeutics, Inc. 0.09 USD 1119.037%
Incyte Corporation 2.67 USD 134.082%
Emergent BioSolutions Inc. -14.85 USD 93.872%